NEW YORK (AP) -- In a highly anticipated decision that could sway the fortunes of a handful of biotechnology companies, the federal patent office has turned back a challenge to patents covering a widely used method for editing genes....
By MALCOLM RITTER, Associated Press: Health
Wed, 02/15/2017 - 3:29pm
NEW YORK (AP) -- In a highly anticipated decision that could sway the fortunes of a handful of biotechnology companies, the federal patent office has turned back a challenge to patents covering a widely used method for editing genes....